The global RIS market produced 445.8 million euros in revenues in 2014 and is expected to grow at a compound annual growth rate of 7.6% to reach 647.4 million euros by 2019, according to a new report from research firm MarketsandMarkets.
Growth will be driven by factors such as improved healthcare information technology systems, growth in the incidence rate of chronic diseases, an increase in government funding for cancer-related research, and growing demand for better healthcare services, MarketsandMarkets said.
